{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:31:59Z","timestamp":1782142319604,"version":"3.54.5"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11675-4","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:02:30Z","timestamp":1773403350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of Junctional Adhesion Molecule-A (JAM-A) in breast cancer metastasis."],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2192-9081","authenticated-orcid":false,"given":"Katarzyna","family":"Gawry\u015b","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rados\u0142aw","family":"Bednarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"\u015awi\u0105tkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"10074","key":"11675_CR1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M (2017) Breast cancer. Lancet 389(10074):1134\u20131150. https:\/\/doi.org\/10.1016\/S0140-6736(16)31891-8 PubMed PMID: 27865536","journal-title":"Lancet"},{"key":"11675_CR2","unstructured":"Cancer Today [Internet] [cited 2025 Jun 20]. Available from: https:\/\/gco.iarc.who.int\/today\/"},{"key":"11675_CR3","unstructured":"Worldwide cancer data World Cancer Research Fund [Internet]. [cited 2025 Oct 9]. Available from: https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/worldwide-cancer-data\/"},{"key":"11675_CR4","unstructured":"Breast cancer [Internet] [cited 2025 Sep 22]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer"},{"issue":"8","key":"11675_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/jpm11080808","volume":"11","author":"A Burguin","year":"2021","unstructured":"Burguin A, Diorio C, Durocher F (2021) Breast Cancer Treatments: Updates and New Challenges. J Personalized Med 11(8):8. https:\/\/doi.org\/10.3390\/jpm11080808","journal-title":"J Personalized Med"},{"issue":"12","key":"11675_CR6","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nrc3628","volume":"13","author":"N Reymond","year":"2013","unstructured":"Reymond N, d\u2019\u00c1gua BB, Ridley AJ (2013) Crossing the endothelial barrier during metastasis. Nat Rev Cancer 13(12):858\u2013870. https:\/\/doi.org\/10.1038\/nrc3628PubMed PMID: 24263189","journal-title":"Nat Rev Cancer"},{"key":"11675_CR7","doi-asserted-by":"publisher","unstructured":"Martin TA (2014) The role of tight junctions in cancer metastasis. Seminars in Cell & Developmental Biology. ;Development of the urogenital system & mTOR Signalling & Tight Junctions in Health and Disease36:224\u201331. https:\/\/doi.org\/10.1016\/j.semcdb.2014.09.008","DOI":"10.1016\/j.semcdb.2014.09.008"},{"issue":"2","key":"11675_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.30699\/ijp.2025.2040168.3350","volume":"20","author":"M Soltan","year":"2025","unstructured":"Soltan M, Naimi A, Hafez Forghan R, Mansourian M (2025) Evaluation of the Role of Claudin-4 Antigen Overexpression in Triple-Negative Breast Cancer Patients: A 5-Year Survival Analysis. Iran J Pathol 20(2):167\u2013172. https:\/\/doi.org\/10.30699\/ijp.2025.2040168.3350PubMed PMID: 40487255; PubMed Central PMCID: PMC12142012","journal-title":"Iran J Pathol"},{"issue":"6","key":"11675_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00428-009-0770-6","volume":"454","author":"AA Blanchard","year":"2009","unstructured":"Blanchard AA, Skliris GP, Watson PH, Murphy LC, Penner C, Tomes L et al (2009) Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch 454(6):647\u2013656. https:\/\/doi.org\/10.1007\/s00428-009-0770-6","journal-title":"Virchows Arch"},{"issue":"4","key":"11675_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/modpathol.2012.187","volume":"26","author":"S Lu","year":"2013","unstructured":"Lu S, Singh K, Mangray S, Tavares R, Noble L, Resnick MB et al (2013) Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype. Mod Pathol 26(4):485\u2013495. https:\/\/doi.org\/10.1038\/modpathol.2012.187PubMed PMID: 23222490; PubMed Central PMCID: PMC4000969","journal-title":"Mod Pathol"},{"key":"11675_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40364-024-00702","volume":"12","author":"S B\u00fcy\u00fccek","year":"2024","unstructured":"B\u00fcy\u00fccek S, Schraps N, Menz A, Lutz F, Chirico V, Viehweger F et al (2024) Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples. Biomark Res 12:154. https:\/\/doi.org\/10.1186\/s40364-024-00702w PubMed PMID: 39658782; PubMed Central PMCID: PMC11633013","journal-title":"Biomark Res"},{"key":"11675_CR12","doi-asserted-by":"publisher","first-page":"110393","DOI":"10.1016\/j.cellsig.2022.110393","volume":"97","author":"CLDN6 inhibits","year":"2022","unstructured":"CLDN6 inhibits (2022) breast cancer cell malignant behavior by suppressing ERK signaling. Cell Signal 97:110393. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110393","journal-title":"Cell Signal"},{"issue":"4","key":"11675_CR13","doi-asserted-by":"publisher","first-page":"e0321105","DOI":"10.1371\/journal.pone.0321105","volume":"20","author":"S B\u00fcy\u00fccek","year":"2025","unstructured":"B\u00fcy\u00fccek S, Viehweger F, Reiswich V, Gorbokon N, Chirico V, Bernreuther C et al (2025) Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors. PLoS ONE 20(4):e0321105. https:\/\/doi.org\/10.1371\/journal.pone.0321105PubMed PMID: 40173205; PubMed Central PMCID: PMC11964279","journal-title":"PLoS ONE"},{"issue":"5","key":"11675_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3892\/ijmm_00000519","volume":"26","author":"TA Martin","year":"2010","unstructured":"Martin TA, Mansel RE, Jiang WG (2010) Loss of occludin leads to the progression of human breast cancer. Int J Mol Med 26(5):723\u2013734 doi:10.3892\/ijmm_00000519 PubMed PMID: 20878095","journal-title":"Int J Mol Med"},{"issue":"22","key":"11675_CR15","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1158\/0008-5472.CAN-20-1829","volume":"80","author":"A Lauko","year":"2020","unstructured":"Lauko A, Mu Z, Gutmann DH, Naik UP, Lathia JD (2020) Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression. Cancer Res 80(22):4878\u20134885. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1829PubMed PMID: 32816855; PubMed Central PMCID: PMC7669553","journal-title":"Cancer Res"},{"issue":"8","key":"11675_CR16","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00018-017-2729-0","volume":"75","author":"T Steinbacher","year":"2017","unstructured":"Steinbacher T, Kummer D, Ebnet K (2017) Junctional adhesion molecule-A: functional diversity through molecular promiscuity. Cell Mol Life Sci 75(8):1393\u20131409. https:\/\/doi.org\/10.1007\/s00018-017-2729-0PubMed PMID: 29238845; PubMed Central PMCID: PMC11105642","journal-title":"Cell Mol Life Sci"},{"key":"11675_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1749-6632","volume":"1257","author":"AC Monteiro","year":"2012","unstructured":"Monteiro AC, Parkos CA (2012) Intracellular mediators of JAM-A\u2013dependent epithelial barrier function. Ann N Y Acad Sci 1257:115\u2013124. https:\/\/doi.org\/10.1111\/j.1749-66322012.06521.x PubMed PMID: 22671597; PubMed Central PMCID: PMC3443962","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"11675_CR18","first-page":"7242","volume":"7","author":"C Zhao","year":"2014","unstructured":"Zhao C, Lu F, Chen H, Zhao X, Sun J, Chen H (2014) Dysregulation of JAM-A plays an important role in human tumor progression. Int J Clin Exp Pathol 7(10):7242\u20137248 PubMed PMID: 25400822; PubMed Central PMCID: PMC4230059","journal-title":"Int J Clin Exp Pathol"},{"key":"11675_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13058-018-1064-1","volume":"20","author":"AO Leech","year":"2018","unstructured":"Leech AO, Vellanki SH, Rutherford EJ, Keogh A, Jahns H, Hudson L et al (2018) Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings. Breast Cancer Res 20:140. https:\/\/doi.org\/10.1186\/s13058-018-1064-1PubMed PMID: 30458861; PubMed Central PMCID: PMC6247757","journal-title":"Breast Cancer Res"},{"issue":"2","key":"11675_CR20","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/bcr2853","volume":"13","author":"EA McSherry","year":"2011","unstructured":"McSherry EA, Brennan K, Hudson L, Hill AD, Hopkins AM (2011) Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res 13(2):R31. https:\/\/doi.org\/10.1186\/bcr2853PubMed PMID: 21429211; PubMed Central PMCID: PMC3219194","journal-title":"Breast Cancer Res"},{"issue":"11","key":"11675_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s13238-014-0088-2","volume":"5","author":"M Cao","year":"2014","unstructured":"Cao M, Nie W, Li J, Zhang Y, Yan X, Guan X et al (2014) MicroRNA-495 induces breast cancer cell migration by targeting JAM-A. Protein Cell 5(11):862\u2013872. https:\/\/doi.org\/10.1007\/s13238-014-0088-2PubMed PMID: 25070379; PubMed Central PMCID: PMC4225486","journal-title":"Protein Cell"},{"issue":"10","key":"11675_CR22","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK (2020) EMT, MET, plasticity and tumor metastasis. Trends Cell Biol 30(10):764\u2013776. https:\/\/doi.org\/10.1016\/j.tcb.2020.07.003 PubMed PMID: 32800658; PubMed Central PMCID: PMC7647095","journal-title":"Trends Cell Biol"},{"issue":"3","key":"11675_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu W, Kang Y (2019) Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev Cell 49(3):361\u2013374. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.010 PubMed PMID: 31063755; PubMed Central PMCID: PMC6506183","journal-title":"Dev Cell"},{"issue":"3","key":"11675_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1152\/physrev.00035.2003","volume":"84","author":"G Bazzoni","year":"2004","unstructured":"Bazzoni G, Dejana E (2004) Endothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis. Physiol Rev 84(3):869\u2013901. https:\/\/doi.org\/10.1152\/physrev.00035.2003","journal-title":"Physiol Rev"},{"issue":"1\u20132","key":"11675_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mrrev.2011.05.002","volume":"728","author":"F van Zijl","year":"2011","unstructured":"van Zijl F, Krupitza G, Mikulits W (2011) Initial steps of metastasis: Cell invasion and endothelial transmigration. Mutat Res 728(1\u20132):23\u201334. https:\/\/doi.org\/10.1016\/j.mrrev.2011.05.002PubMed PMID: 21605699; PubMed Central PMCID: PMC4028085","journal-title":"Mutat Res"},{"issue":"3","key":"11675_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00441-014-1820-1","volume":"355","author":"S Garrido-Urbani","year":"2014","unstructured":"Garrido-Urbani S, Bradfield PF, Imhof BA (2014) Tight junction dynamics: the role of junctional adhesion molecules (JAMs). Cell Tissue Res 355(3):701\u2013715. https:\/\/doi.org\/10.1007\/s00441-014-1820-1","journal-title":"Cell Tissue Res"},{"key":"11675_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40139-016","volume":"4","author":"E Salvador","year":"2016","unstructured":"Salvador E, Burek M, F\u00f6rster CY (2016) Tight Junctions and the Tumor Microenvironment. Curr Pathobiol Rep 4:135\u2013145. https:\/\/doi.org\/10.1007\/s40139-0160106-6 PubMed PMID: 27547510; PubMed Central PMCID: PMC4978755","journal-title":"Curr Pathobiol Rep"},{"issue":"1","key":"11675_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1083\/jcb.142.1.117","volume":"142","author":"I Mart\u00ecn-Padura","year":"1998","unstructured":"Mart\u00ecn-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P et al (1998) Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration. J Cell Biol 142(1):117\u2013127. https:\/\/doi.org\/10.1083\/jcb.142.1.117PubMed PMID: 9660867; PubMed Central PMCID: PMC2133024","journal-title":"J Cell Biol"},{"issue":"17","key":"11675_CR29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0161-5890(99)00122-4","volume":"36","author":"LA Williams","year":"1999","unstructured":"Williams LA, Martin-Padura I, Dejana E, Hogg N, Simmons DL (1999) Identification and characterisation of human Junctional Adhesion Molecule (JAM). Mol Immunol 36(17):1175\u20131188. https:\/\/doi.org\/10.1016\/S0161-5890(99)00122-4","journal-title":"Mol Immunol"},{"issue":"8","key":"11675_CR30","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1182\/blood.V95.8.2600","volume":"95","author":"MB Sobocka","year":"2000","unstructured":"Sobocka MB, Sobocki T, Banerjee P, Weiss C, Rushbrook JI, Norin AJ et al (2000) Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation. Blood 95(8):2600\u20132609. https:\/\/doi.org\/10.1182\/blood.V95.8.2600. Presented in part at the XVIIth Congress of the International Society on Thrombosis and Haemostasis, Washington, DC, August 14\u201321, 1999","journal-title":"Blood"},{"issue":"1","key":"11675_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.gene.2005.08.025","volume":"366","author":"T Sobocki","year":"2006","unstructured":"Sobocki T, Sobocka MB, Babinska A, Ehrlich YH, Banerjee P, Kornecki E (2006) Genomic structure, organization and promoter analysis of the human F11R\/F11 receptor\/junctional adhesion molecule-1\/JAM-A. Gene 366(1):128\u2013144. https:\/\/doi.org\/10.1016\/j.gene.2005.08.025","journal-title":"Gene"},{"issue":"1","key":"11675_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/15216540050176593","volume":"50","author":"SK Gupta","year":"2000","unstructured":"Gupta SK, Pillarisetti K, Ohlstein EH (2000) Platelet Agonist F11 Receptor Is a Member of the Immunoglobulin Superfamily and Identical with Junctional Adhesion Molecule (JAM): Regulation of Expression in Human Endothelial Cells and Macrophages. IUBMB Life 50(1):51\u201356. https:\/\/doi.org\/10.1080\/15216540050176593","journal-title":"IUBMB Life"},{"issue":"5296","key":"11675_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1126\/science.275.5296.73","volume":"275","author":"Z Songyang","year":"1997","unstructured":"Songyang Z, Fanning AS, Fu C, Xu J, Marfatia SM, Chishti AH et al (1997) Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains. Science 275(5296):73\u201377. https:\/\/doi.org\/10.1126\/science.275.5296.73","journal-title":"Science"},{"issue":"13","key":"11675_CR34","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1084\/jem.20071416","volume":"204","author":"MG Laukoetter","year":"2007","unstructured":"Laukoetter MG, Nava P, Lee WY, Severson EA, Capaldo CT, Babbin BA et al (2007) JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med 204(13):3067\u20133076. https:\/\/doi.org\/10.1084\/jem.20071416PubMed PMID: 18039951; PubMed Central PMCID: PMC2150975","journal-title":"J Exp Med"},{"issue":"2","key":"11675_CR35","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ajpath.2014.10.010","volume":"185","author":"LA Mitchell","year":"2015","unstructured":"Mitchell LA, Ward C, Kwon M, Mitchell PO, Quintero DA, Nusrat A et al (2015) Junctional Adhesion Molecule A Promotes Epithelial Tight Junction Assembly to Augment Lung Barrier Function. Am J Pathol 185(2):372\u2013386. https:\/\/doi.org\/10.1016\/j.ajpath.2014.10.010PubMed PMID: 25438062; PubMed Central PMCID: PMC4305184","journal-title":"Am J Pathol"},{"issue":"3","key":"11675_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.immuni.2012.06.017","volume":"37","author":"M Khounlotham","year":"2012","unstructured":"Khounlotham M, Kim W, Peatman E, Nava P, Medina-Contreras O, Addis C et al (2012) Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. Immunity 37(3):563\u2013573. https:\/\/doi.org\/10.1016\/j.immuni.2012.06.017PubMed PMID: 22981539; PubMed Central PMCID: PMC3564580","journal-title":"Immunity"},{"issue":"9","key":"11675_CR37","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1161\/01.ATV.0000234923.79173.99","volume":"26","author":"VG Cooke","year":"2006","unstructured":"Cooke VG, Naik MU, Naik UP (2006) Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice. Arterioscler Thromb Vasc Biol 26(9):2005\u20132011. https:\/\/doi.org\/10.1161\/01.ATV.0000234923.79173.99PubMed PMID: 16809549","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"11675_CR38","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1084\/jem.20082745","volume":"206","author":"Z Mamdouh","year":"2009","unstructured":"Mamdouh Z, Mikhailov A, Muller WA (2009) Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment. J Exp Med 206(12):2795\u20132808. https:\/\/doi.org\/10.1084\/jem.20082745PubMed PMID: 19887395; PubMed Central PMCID: PMC2806621","journal-title":"J Exp Med"},{"issue":"4","key":"11675_CR39","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1055\/s-0037-1613070","volume":"87","author":"A Babinska","year":"2002","unstructured":"Babinska A, Kedees MH, Athar H, Sobocki T, Sobocka MB, Ahmed T et al (2002) Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion. Thromb Haemost 87(4):712\u2013721 PubMed PMID: 12008956","journal-title":"Thromb Haemost"},{"issue":"1","key":"11675_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11010-021-04259-2","volume":"477","author":"K Czubak-Prowizor","year":"2022","unstructured":"Czubak-Prowizor K, Babinska A, Swiatkowska M (2022) The F11 Receptor (F11R)\/Junctional Adhesion Molecule-A (JAM-A) (F11R\/JAM-A) in cancer progression. Mol Cell Biochem 477(1):79\u201398. https:\/\/doi.org\/10.1007\/s11010-021-04259-2PubMed PMID: 34533648; PubMed Central PMCID: PMC8755661","journal-title":"Mol Cell Biochem"},{"key":"11675_CR41","doi-asserted-by":"publisher","first-page":"104389","DOI":"10.1016\/j.critrevonc.2024.104389","volume":"199","author":"OH Rodr\u00edguez-Bejarano","year":"2024","unstructured":"Rodr\u00edguez-Bejarano OH, Parra-L\u00f3pez C, Patarroyo MA (2024) A review concerning the breast cancer-related tumour microenvironment. Crit Rev Oncol\/Hematol 199:104389. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104389","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"2","key":"11675_CR42","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4049\/jimmunol.163.2.553","volume":"163","author":"H Ozaki","year":"1999","unstructured":"Ozaki H, Ishii K, Horiuchi H, Arai H, Kawamoto T, Okawa K et al (1999) Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol 163(2):553\u2013557 PubMed PMID: 10395639","journal-title":"J Immunol"},{"issue":"2","key":"11675_CR43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1189\/jlb.0412205","volume":"95","author":"J Jaczewska","year":"2014","unstructured":"Jaczewska J, Abdulreda MH, Yau CY, Schmitt MM, Schubert I, Berggren PO et al (2014) TNF-\u03b1 and IFN-\u03b3 promote lymphocyte adhesion to endothelial junctional regions facilitating transendothelial migration. J Leukoc Biol 95(2):265\u2013274. https:\/\/doi.org\/10.1189\/jlb.0412205PubMed PMID: 24072879; PubMed Central PMCID: PMC3896659","journal-title":"J Leukoc Biol"},{"issue":"6","key":"11675_CR44","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/s0002-9440(10)63078-7","volume":"159","author":"SK Shaw","year":"2001","unstructured":"Shaw SK, Perkins BN, Lim YC, Liu Y, Nusrat A, Schnell FJ et al (2001) Reduced expression of junctional adhesion molecule and platelet\/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma Does not reduce leukocyte transmigration under flow. Am J Pathol 159(6):2281\u20132291. https:\/\/doi.org\/10.1016\/s0002-9440(10)63078-7PubMed PMID: 11733377; PubMed Central PMCID: PMC1850595","journal-title":"Am J Pathol"},{"issue":"18","key":"11675_CR45","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1091\/mbc.E13-06","volume":"24","author":"AC Monteiro","year":"2013","unstructured":"Monteiro AC, Sumagin R, Rankin CR, Leoni G, Mina MJ, Reiter DM et al (2013) JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function. Mol Biol Cell 24(18):2849\u20132860. https:\/\/doi.org\/10.1091\/mbc.E13-060298 PubMed PMID: 23885123; PubMed Central PMCID: PMC3771947","journal-title":"Mol Biol Cell"},{"issue":"19","key":"11675_CR46","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1182\/blood-2008-04-152330","volume":"113","author":"RR Koenen","year":"2009","unstructured":"Koenen RR, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, Schwarz N et al (2009) Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 113(19):4799\u20134809. https:\/\/doi.org\/10.1182\/blood-2008-04-152330","journal-title":"Blood"},{"issue":"10","key":"11675_CR47","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1161\/ATVBAHA.116.307610","volume":"36","author":"N Reglero-Real","year":"2016","unstructured":"Reglero-Real N, Colom B, Bodkin JV, Nourshargh S, Arteriosclerosis (2016) Thromb Vascular Biology 36(10):2048\u20132057. https:\/\/doi.org\/10.1161\/ATVBAHA.116.307610","journal-title":"Thromb Vascular Biology"},{"issue":"6","key":"11675_CR48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1471-4906(03)00117-0","volume":"24","author":"WA Muller","year":"2003","unstructured":"Muller WA (2003) Leukocyte\u2013endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24(6):326\u2013333. https:\/\/doi.org\/10.1016\/S1471-4906(03)00117-0","journal-title":"Trends Immunol"},{"key":"11675_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-025-02338-2","volume":"24","author":"H Allgayer","year":"2025","unstructured":"Allgayer H, Mahapatra S, Mishra B, Swain B, Saha S, Khanra S et al (2025) Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025. Mol Cancer 24:167. https:\/\/doi.org\/10.1186\/s12943-025-02338-2PubMed PMID: 40483504; PubMed Central PMCID: PMC12144846","journal-title":"Mol Cancer"},{"key":"11675_CR50","doi-asserted-by":"publisher","unstructured":"Liu Z, Choksi S, Kwon HJ, Jiao D, Liu C, Liu Z (2023) gang. Tumor necroptosis-mediated shedding of cell surface proteins promotes metastasis of breast cancer by suppressing anti-tumor immunity. Breast Cancer Research. ;25(1):10. https:\/\/doi.org\/10.1186\/s13058-023-01604-9","DOI":"10.1186\/s13058-023-01604-9"},{"key":"11675_CR51","doi-asserted-by":"publisher","unstructured":"Rath D, Rapp V, Schwartz J, Winter S, Emschermann F, Arnold D et al (2022) Homophilic Interaction Between Transmembrane-JAM-A and Soluble JAM-A Regulates Thrombo-Inflammation. JACC: Basic to Translational Science. ;7(5):445\u201361. https:\/\/doi.org\/10.1016\/j.jacbts.2022.03.003","DOI":"10.1016\/j.jacbts.2022.03.003"},{"issue":"1","key":"11675_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1529\/biophysj.108.135491","volume":"96","author":"EP Wojcikiewicz","year":"2009","unstructured":"Wojcikiewicz EP, Koenen RR, Fraemohs L, Minkiewicz J, Azad H, Weber C et al (2009) LFA-1 Binding Destabilizes the JAM-A Homophilic Interaction During Leukocyte Transmigration. Biophys J 96(1):285\u2013293. https:\/\/doi.org\/10.1529\/biophysj.108.135491PubMed PMID: 18849408; PubMed Central PMCID: PMC2710021","journal-title":"Biophys J"},{"issue":"2","key":"11675_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ni755","volume":"3","author":"G Ostermann","year":"2002","unstructured":"Ostermann G, Weber KSC, Zernecke A, Schr\u00f6der A, Weber C (2002) JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 3(2):151\u2013158. https:\/\/doi.org\/10.1038\/ni755PubMed PMID: 11812992","journal-title":"Nat Immunol"},{"issue":"9","key":"11675_CR54","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nri2156","volume":"7","author":"K Ley","year":"2007","unstructured":"Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7(9):678\u2013689. https:\/\/doi.org\/10.1038\/nri2156","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"11675_CR55","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/35067088","volume":"2","author":"S Tsukita","year":"2001","unstructured":"Tsukita S, Furuse M, Itoh M (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2(4):285\u2013293 doi:10.1038\/35067088 PubMed PMID: 11283726","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"11675_CR56","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1158\/0008-5472.CAN-07-3057","volume":"68","author":"MU Naik","year":"2008","unstructured":"Naik MU, Naik TU, Suckow AT, Duncan MK, Naik UP (2008) Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 68(7):2194\u20132203. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-3057PubMed PMID: 18381425","journal-title":"Cancer Res"},{"issue":"6","key":"11675_CR57","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/ijc.24498","volume":"125","author":"EA McSherry","year":"2009","unstructured":"McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G et al (2009) JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer 125(6):1343\u20131351. https:\/\/doi.org\/10.1002\/ijc.24498PubMed PMID: 19533747","journal-title":"Int J Cancer"},{"issue":"6","key":"11675_CR58","doi-asserted-by":"publisher","first-page":"e21242","DOI":"10.1371\/journal.pone.0021242","volume":"6","author":"M Murakami","year":"2011","unstructured":"Murakami M, Giampietro C, Giannotta M, Corada M, Torselli I, Orsenigo F et al (2011) Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression. PLoS ONE 6(6):e21242. https:\/\/doi.org\/10.1371\/journal.pone.0021242PubMed PMID: 21695058; PubMed Central PMCID: PMC3117883","journal-title":"PLoS ONE"},{"issue":"12","key":"11675_CR59","doi-asserted-by":"publisher","first-page":"11665","DOI":"10.1074\/jbc.M412650200","volume":"280","author":"KJ Mandell","year":"2005","unstructured":"Mandell KJ, Babbin BA, Nusrat A, Parkos CA (2005) Junctional Adhesion Molecule 1 Regulates Epithelial Cell Morphology through Effects on \u03b21 Integrins and Rap1 Activity *. J Biol Chem 280(12):11665\u201311674. jbc.M412650200 PubMed PMID: 15677455","journal-title":"J Biol Chem"},{"issue":"7","key":"11675_CR60","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1091\/mbc.e08-10-1014","volume":"20","author":"EA Severson","year":"2009","unstructured":"Severson EA, Lee WY, Capaldo CT, Nusrat A, Parkos CA (2009) Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration. Mol Biol Cell 20(7):1916\u20131925. https:\/\/doi.org\/10.1091\/mbc.e08-10-1014PubMed PMID: 19176753; PubMed Central PMCID: PMC2663925","journal-title":"Mol Biol Cell"},{"issue":"7","key":"11675_CR61","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3390\/biomedicines12071423","volume":"12","author":"T Ren","year":"2024","unstructured":"Ren T, Zheng Y, Liu F, Liu C, Zhang B, Ren H et al (2024) Identification and Validation of JAM-A as a Novel Prognostic and Immune Factor in Human Tumors. Biomedicines 12(7):1423. https:\/\/doi.org\/10.3390\/biomedicines12071423PubMed PMID: 39061997; PubMed Central PMCID: PMC11275048","journal-title":"Biomedicines"},{"key":"11675_CR62","doi-asserted-by":"publisher","first-page":"101652","DOI":"10.1016\/j.bbrep.2024.101652","volume":"38","author":"Y Hwang","year":"2024","unstructured":"Hwang Y, Kim Y, Min J, Jung J (2024) Identification of novel membrane markers in circulating tumor cells of mesenchymal state in breast cancer. Biochem Biophys Rep 38:101652. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101652PubMed PMID: 38375422; PubMed Central PMCID: PMC10875194","journal-title":"Biochem Biophys Rep"},{"key":"11675_CR63","doi-asserted-by":"publisher","first-page":"e19703","DOI":"10.7717\/peerj.19703","volume":"13","author":"L Hao","year":"2025","unstructured":"Hao L, Zheng L (2025) Clinical significance and heterogeneity of circulating tumor cells and clusters in breast cancer subtypes. PeerJ 13:e19703. https:\/\/doi.org\/10.7717\/peerj.19703PubMed PMID: 40656955; PubMed Central PMCID: PMC12255241","journal-title":"PeerJ"},{"issue":"8","key":"11675_CR64","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.32604\/biocell.2023.028343","volume":"47","author":"X Li","year":"2023","unstructured":"Li X, Zheng J, Zhu J, Huang X, Zhu H, Chen B (2023) Circulating tumor cells: Biological features and survival mechanisms. BIOCELL 47(8):1771\u20131781. https:\/\/doi.org\/10.32604\/biocell.2023.028343","journal-title":"BIOCELL"},{"issue":"50","key":"11675_CR65","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1038\/onc.2010.386","volume":"29","author":"M G\u00f6tte","year":"2010","unstructured":"G\u00f6tte M, Mohr C, Koo CY, Stock C, Vaske AK, Viola M et al (2010) miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene 29(50):6569\u20136580. https:\/\/doi.org\/10.1038\/onc.2010.386","journal-title":"Oncogene"},{"issue":"22","key":"11675_CR66","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/onc.2012.276","volume":"32","author":"K Brennan","year":"2013","unstructured":"Brennan K, McSherry EA, Hudson L, Kay EW, Hill ADK, Young LS et al (2013) Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling. Oncogene 32(22):2799\u20132804. https:\/\/doi.org\/10.1038\/onc.2012.276PubMed PMID: 22751120","journal-title":"Oncogene"},{"issue":"6","key":"11675_CR67","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/ijc.27772","volume":"132","author":"L Goetsch","year":"2013","unstructured":"Goetsch L, Haeuw JF, Beau-Larvor C, Gonzalez A, Zanna L, Malissard M et al (2013) A novel role for junctional adhesion molecule-A in tumor proliferation: Modulation by an anti-JAM-A monoclonal antibody. Int J Cancer 132(6):1463\u20131474. https:\/\/doi.org\/10.1002\/ijc.27772","journal-title":"Int J Cancer"},{"key":"11675_CR68","doi-asserted-by":"publisher","unstructured":"C MM, I F (2010) Inactivation of junctional adhesion molecule-A enhances antitumoral immune response by promoting dendritic cell and T lymphocyte infiltration. Cancer Res 70(5). https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1703PubMed PMID: 20160037","DOI":"10.1158\/0008-5472.CAN-09-1703"},{"issue":"4","key":"11675_CR69","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/cancers13040871","volume":"13","author":"RGB Cruz","year":"2021","unstructured":"Cruz RGB, Madden SF, Richards CE, Vellanki SH, Jahns H, Hudson L et al (2021) Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1. Cancers (Basel) 13(4):871. https:\/\/doi.org\/10.3390\/cancers13040871PubMed PMID: 33669586; PubMed Central PMCID: PMC7922773","journal-title":"Cancers (Basel)"},{"issue":"4","key":"11675_CR70","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/cells11040735","volume":"11","author":"RGB Cruz","year":"2022","unstructured":"Cruz RGB, Madden SF, Brennan K, Hopkins AM (2022) A Transcriptional Link between HER2, JAM-A and FOXA1 in Breast Cancer. Cells 11(4):735 doi:10.3390\/cells11040735 PubMed PMID: 35203384; PubMed Central PMCID: PMC8870165","journal-title":"Cells"},{"key":"11675_CR71","doi-asserted-by":"publisher","unstructured":"Thiery JP, Acloque H, Huang RYJ, Nieto MA (2009) Epithelial-Mesenchymal Transitions in Development and Disease. Cell. ;139(5):871\u201390. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007 PubMed PMID: 19945376","DOI":"10.1016\/j.cell.2009.11.007"},{"issue":"15","key":"11675_CR72","doi-asserted-by":"publisher","first-page":"7326","DOI":"10.3390\/ijms26157326","volume":"26","author":"E Cecerska-Hery\u0107","year":"2025","unstructured":"Cecerska-Hery\u0107 E, Jerzyk A, Goszka M, Polikowska A, Rachwalska J, Serwin N et al (2025) TGF-\u03b2 Signaling in Cancer: Mechanisms of Progression and Therapeutic Targets. Int J Mol Sci 26(15):7326. https:\/\/doi.org\/10.3390\/ijms26157326PubMed PMID: 40806457; PubMed Central PMCID: PMC12347881","journal-title":"Int J Mol Sci"},{"key":"11675_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2025.05.004","volume":"85","author":"W Luo","year":"2025","unstructured":"Luo W, Shi Q, Han M, Zhang Z, Reiter RJ, Ashrafizadeh M et al (2025) TGF-\u03b2-driven EMT in cancer progression and drug resistance. Cytokine Growth Factor Rev 85:11\u201325. https:\/\/doi.org\/10.1016\/j.cytogfr.2025.05.004","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"11675_CR74","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12282-011-0321-2","volume":"19","author":"T Imamura","year":"2012","unstructured":"Imamura T, Hikita A, Inoue Y (2012) The roles of TGF-\u03b2 signaling in carcinogenesis and breast cancer metastasis. Breast Cancer 19(2):118\u2013124. https:\/\/doi.org\/10.1007\/s12282-011-0321-2","journal-title":"Breast Cancer"},{"issue":"18","key":"11675_CR75","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1016\/j.ejca.2012","volume":"48","author":"Y Wang","year":"2012","unstructured":"Wang Y, Lui WY (2012) Transforming growth factor-\u03b21 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion. Eur J Cancer 48(18):3475\u20133487. https:\/\/doi.org\/10.1016\/j.ejca.201204.016 PubMed PMID: 22647687","journal-title":"Eur J Cancer"},{"issue":"8","key":"11675_CR76","doi-asserted-by":"publisher","first-page":"e43752","DOI":"10.1371\/journal.pone.0043752","volume":"7","author":"AM Imbert","year":"2012","unstructured":"Imbert AM, Garulli C, Choquet E, Koubi M, Aurrand-Lions M, Chabannon C (2012) CD146 Expression in Human Breast Cancer Cell Lines Induces Phenotypic and Functional Changes Observed in Epithelial to Mesenchymal Transition. PLoS ONE 7(8):e43752. https:\/\/doi.org\/10.1371\/journal.pone.0043752PubMed PMID: 22952755; PubMed Central PMCID: PMC3431364","journal-title":"PLoS ONE"},{"issue":"4","key":"11675_CR77","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/embor.2011.16","volume":"12","author":"P Nava","year":"2011","unstructured":"Nava P, Capaldo CT, Koch S, Kolegraff K, Rankin CR, Farkas AE et al (2011) JAM-A regulates epithelial proliferation through Akt\/\u03b2\u2010catenin signalling. EMBO Rep 12(4):314\u2013320. https:\/\/doi.org\/10.1038\/embor.2011.16","journal-title":"EMBO Rep"},{"issue":"3","key":"11675_CR78","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/cjp2.313","volume":"9","author":"CH Li","year":"2023","unstructured":"Li CH, Fang CY, Chan MH, Lu PJ, Ger LP, Chu JS et al (2023) The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple-negative breast cancers. J Pathology: Clin Res 9(3):165\u2013181. https:\/\/doi.org\/10.1002\/cjp2.313","journal-title":"J Pathology: Clin Res"},{"issue":"7","key":"11675_CR79","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1002\/stem.2021","volume":"33","author":"PS Thiagarajan","year":"2015","unstructured":"Thiagarajan PS, Hitomi M, Hale JS, Alvarado AG, Otvos B, Sinyuk M et al (2015) Development of a fluorescent reporter system to delineate cancer stem cells in triple-negative breast cancer. Stem Cells 33(7):2114\u20132125. https:\/\/doi.org\/10.1002\/stem.2021PubMed PMID: 25827713; PubMed Central PMCID: PMC4494654","journal-title":"Stem Cells"},{"issue":"4","key":"11675_CR80","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/bip.22503","volume":"102","author":"A Babinska","year":"2014","unstructured":"Babinska A, Clement CC, Swiatkowska M, Szymanski J, Shon A, Ehrlich YH et al (2014) Development of new antiatherosclerotic and antithrombotic drugs utilizing F11 receptor (F11R\/JAM-A) peptides. Biopolymers 102(4):322\u2013334. https:\/\/doi.org\/10.1002\/bip.22503PubMed PMID: 24801754","journal-title":"Biopolymers"},{"issue":"2","key":"11675_CR81","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10549-019-05471-x","volume":"179","author":"R Bednarek","year":"2020","unstructured":"Bednarek R, Selmi A, Wojkowska D, Karolczak K, Popielarski M, Stasiak M et al (2020) Functional inhibition of F11 receptor (F11R\/junctional adhesion molecule-A\/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment. Breast Cancer Res Treat 179(2):325\u2013335 -x PubMed PMID: 31650345; PubMed Central PMCID: PMC6987052","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"11675_CR82","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.21873\/anticanres.13230","volume":"39","author":"SH Vellanki","year":"2019","unstructured":"Vellanki SH, Cruz RGB, Richards CE, Smith YE, Hudson L, Jahns H et al (2019) Antibiotic Tetrocarcin-A Down-regulates JAM-A, IAPs and Induces Apoptosis in Triple-negative Breast Cancer Models. Anticancer Res 39(3):1197\u20131204. https:\/\/doi.org\/10.21873\/anticanres.13230PubMed PMID: 30842150","journal-title":"Anticancer Res"},{"key":"11675_CR83","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12935-023-03023-4","volume":"23","author":"R Bednarek","year":"2023","unstructured":"Bednarek R, Wojkowska DW, Braun M, Watala C, Salifu MO, Swiatkowska M et al (2023) Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R\/JAM\u2013A protein. Cancer Cell Int 23:160. https:\/\/doi.org\/10.1186\/s12935-023-03023-4PubMed PMID: 37563645; PubMed Central PMCID: PMC10416405","journal-title":"Cancer Cell Int"},{"issue":"5","key":"11675_CR84","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/cancers14051303","volume":"14","author":"YE Smith","year":"2022","unstructured":"Smith YE, Wang G, Flynn CL, Madden SF, MacEneaney O, Cruz RGB et al (2022) Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression. Cancers (Basel) 14(5):1303. https:\/\/doi.org\/10.3390\/cancers14051303PubMed PMID: 35267611; PubMed Central PMCID: PMC8909510","journal-title":"Cancers (Basel)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11675-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11675-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11675-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:02:32Z","timestamp":1773403352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11675-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11675"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11675-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"488"}}